Stay updated with breaking news from Cellmax Life. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Blood-based biomarker tests for colorectal cancer could soon be cleared by U.S. regulators, opening the doors to a new, more convenient way to screen for the disease.
SUNNYVALE, Calif. April 6, 2023 (PRWEB) April 06, 2023 -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood
If colon cancer blood tests eventually win FDA approval and Medicare reimbursement, their use could become more widespread. But first this approach needs to match up against the current standard.
SUNNYVALE, Calif. (PRWEB) February 21, 2023 -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today
NEW YORK, UNITED STATES, March 10, 2022/ EINPresswire.com/-- According to The Insight Partners market research titled' Colorectal Cancer Market Forecast to 2027– Global Analysis and Forecasts by Modality, and End User'. The global Colorectal Cancer market is anticipated to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The symptoms shown by the patients...